Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)
CNY 21.03
(2.14%)
CNY 21.03
(2.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.59 Billion CNY | -23.85% |
| 2022 | 6.03 Billion CNY | 16.3% |
| 2021 | 5.18 Billion CNY | 13.5% |
| 2020 | 4.57 Billion CNY | 15.98% |
| 2019 | 3.94 Billion CNY | 2.54% |
| 2018 | 3.84 Billion CNY | 8.92% |
| 2017 | 3.53 Billion CNY | 12.71% |
| 2016 | 3.13 Billion CNY | 34.52% |
| 2015 | 2.32 Billion CNY | 13.87% |
| 2014 | 2.04 Billion CNY | 24.28% |
| 2013 | 1.64 Billion CNY | 15.99% |
| 2012 | 1.41 Billion CNY | 19.58% |
| 2011 | 1.18 Billion CNY | 175.46% |
| 2010 | 430.63 Million CNY | 61.68% |
| 2009 | 266.34 Million CNY | 35.48% |
| 2008 | 196.59 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.67 Billion CNY | 1.6% |
| 2024 Q2 | 4.77 Billion CNY | 2.25% |
| 2024 Q3 | 4.68 Billion CNY | -1.86% |
| 2023 Q4 | 4.59 Billion CNY | -15.34% |
| 2023 Q3 | 5.42 Billion CNY | -7.87% |
| 2023 FY | 4.59 Billion CNY | -23.85% |
| 2023 Q2 | 5.89 Billion CNY | -1.59% |
| 2023 Q1 | 5.98 Billion CNY | -0.78% |
| 2022 Q3 | 5.76 Billion CNY | -0.96% |
| 2022 Q2 | 5.82 Billion CNY | 3.99% |
| 2022 FY | 6.03 Billion CNY | 16.3% |
| 2022 Q1 | 5.59 Billion CNY | 7.85% |
| 2022 Q4 | 6.03 Billion CNY | 4.71% |
| 2021 Q1 | 4.6 Billion CNY | 0.74% |
| 2021 FY | 5.18 Billion CNY | 13.5% |
| 2021 Q2 | 4.58 Billion CNY | -0.49% |
| 2021 Q4 | 5.18 Billion CNY | 1.36% |
| 2021 Q3 | 5.12 Billion CNY | 11.71% |
| 2020 FY | 4.57 Billion CNY | 15.98% |
| 2020 Q1 | 4.07 Billion CNY | 3.39% |
| 2020 Q2 | 4.39 Billion CNY | 7.77% |
| 2020 Q3 | 4.61 Billion CNY | 5.14% |
| 2020 Q4 | 4.57 Billion CNY | -1.01% |
| 2019 Q1 | 3.88 Billion CNY | 0.93% |
| 2019 FY | 3.94 Billion CNY | 2.54% |
| 2019 Q2 | 3.87 Billion CNY | -0.26% |
| 2019 Q3 | 4.03 Billion CNY | 4.26% |
| 2019 Q4 | 3.94 Billion CNY | -2.31% |
| 2018 Q2 | 3.83 Billion CNY | 4.87% |
| 2018 FY | 3.84 Billion CNY | 8.92% |
| 2018 Q4 | 3.84 Billion CNY | 4.69% |
| 2018 Q3 | 3.67 Billion CNY | -4.14% |
| 2018 Q1 | 3.65 Billion CNY | 3.49% |
| 2017 Q4 | 3.53 Billion CNY | 4.44% |
| 2017 FY | 3.53 Billion CNY | 12.71% |
| 2017 Q3 | 3.38 Billion CNY | 6.86% |
| 2017 Q2 | 3.16 Billion CNY | -1.3% |
| 2017 Q1 | 3.2 Billion CNY | 2.33% |
| 2016 Q4 | 3.13 Billion CNY | 0.98% |
| 2016 Q2 | 2.56 Billion CNY | 5.51% |
| 2016 Q1 | 2.42 Billion CNY | 4.35% |
| 2016 FY | 3.13 Billion CNY | 34.52% |
| 2016 Q3 | 3.1 Billion CNY | 21.0% |
| 2015 Q3 | 2.18 Billion CNY | 0.16% |
| 2015 Q2 | 2.17 Billion CNY | 6.08% |
| 2015 Q1 | 2.05 Billion CNY | 0.49% |
| 2015 FY | 2.32 Billion CNY | 13.87% |
| 2015 Q4 | 2.32 Billion CNY | 6.64% |
| 2014 Q4 | 2.04 Billion CNY | 4.18% |
| 2014 FY | 2.04 Billion CNY | 24.28% |
| 2014 Q2 | 1.96 Billion CNY | 13.31% |
| 2014 Q1 | 1.73 Billion CNY | 5.39% |
| 2014 Q3 | 1.96 Billion CNY | -0.1% |
| 2013 Q2 | 1.54 Billion CNY | 3.81% |
| 2013 Q4 | 1.64 Billion CNY | 4.06% |
| 2013 Q3 | 1.58 Billion CNY | 2.18% |
| 2013 FY | 1.64 Billion CNY | 15.99% |
| 2013 Q1 | 1.49 Billion CNY | 5.08% |
| 2012 Q1 | 1.19 Billion CNY | 0.77% |
| 2012 FY | 1.41 Billion CNY | 19.58% |
| 2012 Q2 | 1.27 Billion CNY | 6.36% |
| 2012 Q3 | 1.37 Billion CNY | 8.35% |
| 2012 Q4 | 1.41 Billion CNY | 2.97% |
| 2011 Q3 | 1.19 Billion CNY | 108.24% |
| 2011 Q2 | 574.31 Million CNY | 0.0% |
| 2011 Q4 | 1.18 Billion CNY | -0.81% |
| 2011 FY | 1.18 Billion CNY | 175.46% |
| 2010 FY | 430.63 Million CNY | 61.68% |
| 2010 Q4 | 430.63 Million CNY | 0.0% |
| 2009 FY | 266.34 Million CNY | 35.48% |
| 2008 FY | 196.59 Million CNY | 0.0% |